|
Notice:
|
|
Suspension of shipments during Golden Week Holidays: From 4 May to 11 May, deadline 21 April.
|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
14351R-3 |
| Symbol |
CG14351 |
Full Name |
CG14351 |
| CG No |
CG14351 |
Old CG No |
CG14351 |
| Synonyms |
tartan/capricious-like, CT33985, CG14351 |
| Accession No (Link to NCBI) |
NM_134763.1 |
| Inserted Chr. |
ll |
| Insertional Mutation |
semi-lethal |
| Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Kurusu M, Cording A, Taniguchi M, Menon K, Suzuki E, Zinn K.
A screen of cell-surface molecules identifies leucine-rich repeat proteins as key mediators of synaptic target selection.
Neuron (2008) 59(6) 972-85
[
PubMed ID = 18817735
]
[
RRC reference
]
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K.
A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction.
PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD.
Zyxin links fat signaling to the hippo pathway.
PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgGGCCGAACGACAACAGCTTTA |
| Primer Seq. 3' |
aatctagaggtaccTCGGGAATGTGACTGAGCTGA |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 GGCCGAACGA CAACAGCTTT ACCAGCAGCG ACCACGCCCC TGNTCCTGCT ACTCCCACTT
0061 ATCCTGGGCA GGCTCCACGT GGCCCACGCC CAGTGTCCTT GGCAGCGAGA TGTGCCCGAC
0121 CTGCAGACGA GCTGCATCTG TGCCTACAAC CTGGGCAGAG AGCTATCCGT GCAGTGTGAT
0181 CAGGTGGACT TTTCGCAACT CCTGGCTGCG ATGAACACCC ATGCCCGTCT GAAGCCCGTC
0241 GGATTTGCTG TACGTGAACA ACTCCACGAT TTCCGAGCTT CCCGACGCCG TTTTCAGCAA
0301 TTTGAGCCTG CACAATNTgC AGCTCTCGAG CTGCGGCATC CAGAGGATTG CGACGGGTGC
0361 CTTTAAGGGC CAGGAGTCGG TGTTGCGGAA TCTCAATCTG CAGGATAATC TGNNGGCCGA
0421 CGTGCCAGTG GAGGCGCTCA AGGTCCTGGG CAAGCTGAAC CTGCTGGATT TGTCAAAAAA
0481 TCAGCTCAGT CACATTCCCG A |
| in silico PCR Fragment |
0001 GGCCGAACGA CAACAGCTTT ACCAGCAGCG ACCACGCCCC TGCTCCTGCT ACTCCCACTT
0061 ATCCTGGGCA GGCTCCACGT GGCCCACGCC CAGTGTCCTT GGCAGCGAGA TGTGCCCGAC
0121 CTGCAGACGA GCTGCATCTG TGCCTACAAC CTGGGCAGAG AGCTATCCGT GCAGTGTGAT
0181 CAGGTGGACT TTTCGCAACT CCTGGCTGCG ATGAACACCC ATGCCCGTCT GAAGCCCGT-
0241 GGATTTGCTG TACGTGAACA ACTCCACGAT TTCCGAGCTT CCCGACGCCG TTTTCAGCAA
0301 TTTGAGCCTG CACAATTTGC AGCTCTCGAG CTGCGGCATC CAGAGGATTG CGACGGGTGC
0361 CTTTAAGGGC CAGGAGTCGG TGTTGCGGAA TCTCAATCTG CAGGATAATC TGCTGGCCGA
0421 CGTGCCAGTG GAGGCGCTCA AGGTCCTGGG CAAGCTGAAC CTGCTGGATT TGTCAAAAAA
0481 TCAGCTCAGT CACATTCCCG A |
| Assemble Data |
14351R-3.IR_full 1 GGCCGAACGACAACAGCTTTACCAGCAGCGACCACGCCCCTGNTCCTGCTACTCCCACTT 60
|||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||
14351R-3.in silico 1 GGCCGAACGACAACAGCTTTACCAGCAGCGACCACGCCCCTGCTCCTGCTACTCCCACTT 60
14351R-3.IR_full 61 ATCCTGGGCAGGCTCCACGTGGCCCACGCCCAGTGTCCTTGGCAGCGAGATGTGCCCGAC 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14351R-3.in silico 61 ATCCTGGGCAGGCTCCACGTGGCCCACGCCCAGTGTCCTTGGCAGCGAGATGTGCCCGAC 120
14351R-3.IR_full 121 CTGCAGACGAGCTGCATCTGTGCCTACAACCTGGGCAGAGAGCTATCCGTGCAGTGTGAT 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14351R-3.in silico 121 CTGCAGACGAGCTGCATCTGTGCCTACAACCTGGGCAGAGAGCTATCCGTGCAGTGTGAT 180
14351R-3.IR_full 181 CAGGTGGACTTTTCGCAACTCCTGGCTGCGATGAACACCCATGCCCGTCTGAAGCCCGTC 240
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14351R-3.in silico 181 CAGGTGGACTTTTCGCAACTCCTGGCTGCGATGAACACCCATGCCCGTCTGAAGCCCGT- 240
14351R-3.IR_full 241 GGATTTGCTGTACGTGAACAACTCCACGATTTCCGAGCTTCCCGACGCCGTTTTCAGCAA 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14351R-3.in silico 241 GGATTTGCTGTACGTGAACAACTCCACGATTTCCGAGCTTCCCGACGCCGTTTTCAGCAA 300
14351R-3.IR_full 301 TTTGAGCCTGCACAATNTGCAGCTCTCGAGCTGCGGCATCCAGAGGATTGCGACGGGTGC 360
|||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||
14351R-3.in silico 301 TTTGAGCCTGCACAATTTGCAGCTCTCGAGCTGCGGCATCCAGAGGATTGCGACGGGTGC 360
14351R-3.IR_full 361 CTTTAAGGGCCAGGAGTCGGTGTTGCGGAATCTCAATCTGCAGGATAATCTGNNGGCCGA 420
|||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||
14351R-3.in silico 361 CTTTAAGGGCCAGGAGTCGGTGTTGCGGAATCTCAATCTGCAGGATAATCTGCTGGCCGA 420
14351R-3.IR_full 421 CGTGCCAGTGGAGGCGCTCAAGGTCCTGGGCAAGCTGAACCTGCTGGATTTGTCAAAAAA 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14351R-3.in silico 421 CGTGCCAGTGGAGGCGCTCAAGGTCCTGGGCAAGCTGAACCTGCTGGATTTGTCAAAAAA 480
14351R-3.IR_full 481 TCAGCTCAGTCACATTCCCGA 501
|||||||||||||||||||||
14351R-3.in silico 481 TCAGCTCAGTCACATTCCCGA 501
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
1 |
6 |
NM_134763.1 |
CG14351-RA (CG14351), mRNA |
| 0 |
0 |
4 |
4 |
4 |
NM_001014571.1 |
CG33556-RA (form3), mRNA |
| 0 |
0 |
3 |
6 |
3 |
NM_143516.2 |
CG15529-RA (CG15529), mRNA |
| 0 |
0 |
3 |
6 |
2 |
NM_167560.1 |
CG32563-RA (CG32563), mRNA |
| 0 |
0 |
2 |
5 |
3 |
NM_132371.1 |
CG15314-RA (CG15314), mRNA |
| 0 |
0 |
2 |
4 |
8 |
NM_001014630.1 |
CG33547-RA (Rim), mRNA |
| 0 |
0 |
2 |
3 |
17 |
NM_167686.1 |
CG11940-RB, transcript variant B (CG11940), mRNA |
| 0 |
0 |
2 |
3 |
17 |
NM_134519.1 |
CG11940-RA, transcript variant A (CG11940), mRNA |
| 0 |
0 |
2 |
2 |
9 |
NM_176359.1 |
CG9614-RK, transcript variant K (pip), mRNA |
| 0 |
0 |
2 |
2 |
2 |
NM_135744.1 |
CG6180-RA (CG6180), mRNA |
| 0 |
0 |
1 |
4 |
16 |
NM_080055.2 |
CG3895-RA (ph-d), mRNA |
| 0 |
0 |
1 |
4 |
6 |
NM_132689.2 |
CG11151-RA (CG11151), mRNA |
| 0 |
0 |
1 |
4 |
5 |
NM_079149.3 |
CG17046-RA, transcript variant A (klar), mRNA |
| 0 |
0 |
1 |
4 |
4 |
NM_001043111.1 |
CG17046-RB, transcript variant B (klar), mRNA |
| 0 |
0 |
1 |
4 |
3 |
NM_142881.2 |
CG6763-RA (CG6763), mRNA |
| 0 |
0 |
1 |
3 |
6 |
NM_169609.1 |
CG31304-RA (CG31304), mRNA |
| 0 |
0 |
1 |
2 |
7 |
NM_142351.2 |
CG12265-RA (CG12265), mRNA |
| 0 |
0 |
1 |
2 |
6 |
NM_142075.1 |
CG14358-RA (CG14358), mRNA |
| 0 |
0 |
1 |
2 |
4 |
NM_132415.1 |
CG9806-RA (CG9806), mRNA |
| 0 |
0 |
1 |
2 |
4 |
NM_166632.1 |
CG5594-RB, transcript variant B (CG5594), mRNA |
| 0 |
0 |
1 |
2 |
4 |
NM_131901.2 |
CG5594-RC, transcript variant C (CG5594), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_132789.2 |
CG6170-RA, transcript variant A (HDAC6), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167436.1 |
CG6170-RB, transcript variant B (HDAC6), mRNA |
| 0 |
0 |
1 |
2 |
3 |
NM_167437.1 |
CG6170-RC, transcript variant C (HDAC6), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_176465.1 |
CG31211-RC, transcript variant C (CG31211), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_141874.2 |
CG31211-RA, transcript variant A (CG31211), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_176464.1 |
CG31211-RB, transcript variant B (CG31211), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_132248.2 |
CG12125-RA (CG12125), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_134319.3 |
CG10033-RD, transcript variant D (for), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_058142.3 |
CG10033-RE, transcript variant E (for), mRNA |
|
|
|
